Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and our environment safer, healthier and more sustainable. From the food you eat, to the water you drink, to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate.
Eurofins is the global leader in food, environment, pharmaceutical and cosmetic product testing and in agroscience Contract Research Organisation services. Eurofins is one of the market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and in the support of clinical studies, as well as having an emerging global presence in Contract Development and Manufacturing Organisations. The Group also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products.
In over just 30 years, Eurofins has grown from one laboratory in Nantes, France to 55,000 staff across a decentralised and entrepreneurial network of 900 laboratories in over 50 countries. Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products.
Transplant Genomics Inc. ("TGI") is a molecular diagnostics company committed to improving organ transplant outcomes with non-invasive serial monitoring guided by biomarkers. TGI's product portfolio of both individual and combined whole blood gene expression and donor derived cell-free DNA testing is capable of reliably ruling out subclinical kidney rejection and acute rejection in kidney transplant patients. In addition to kidney transplantation testing, our newest product for liver transplant patients is a blood-based biomarker assay designed to rule out rejection as immunosuppression therapy is optimized.
Director, National Market Access ("Director") will partner with and report to the VP of Market Access or Finance Leader and communicate regularly with the Director of Billing. The Director will be responsible for managing and supporting the administrative and internal operational aspects of the managed care contracting department on a regional and national level. This position would serve as a conduit between Billing, Payor Relations credentialing and enrollment functions and third-party payors, including Medicare and Medicaid programs, to resolve issues related to reimbursement, language, and other disputes to create revenue optimization. If requested, the Director will fulfill these same functions for other Eurofins third party billing businesses.
Essential Job Duties and Responsibilities:
Essential Knowledge, Skills and Abilities:
Physical Requirements:
The essential physical and mental requirements described here are representative of those that must be met by an employee to successfully perform the essential functions of the job. Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions.
Schedule:
What we offer:
Eurofins USA Clinical Diagnostics is a Disabled and Veteran Equal Employment Opportunity employer.